Ebola nasal spray vaccine found to 'offer long-term protection'

Scientists at the University of Texas are developing the breathable vaccine It has been shown to protect monkeys against the deadly virus Next step is to test vaccine on humans in phase one clinical trials Researcherssaidrespiratoryvaccine could overcome logistical problems of storing,transporting and administeringinjectablevaccines

By Lizzie Parry for MailOnline

Published: 08:47 EST, 4 November 2014 | Updated: 13:27 EST, 4 November 2014

305 shares

8

View comments

A nasal spray being developed as a potential vaccine for the deadly Ebola virus has been found to be effective.

Scientists at the University of Texas discovered the breathable vaccine offers long-term protection during pre-clinical trials with monkeys.

Since the current outbreak erupted in West Africa earlier this year, almost 5,000 people have lost their lives - the majority in Sierra Leone, Liberia and Guinea.

A number of injectable experimental vaccines are being trialled in the US, UK and Mali, with plans to extend human trials into other parts of Europe, Gabon and Kenya.

View post:
Ebola nasal spray vaccine found to 'offer long-term protection'